Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Vidal SJ"" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł:
Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques.
Autorzy:
Aid M; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Vidal SJ; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Piedra-Mora C; Department of Comparative Pathobiology, Section of Pathology, Tufts University Cummings School of Veterinary Medicine, North Grafton, Massachusetts, United States of America.
Ducat S; Department of Comparative Pathobiology, Section of Pathology, Tufts University Cummings School of Veterinary Medicine, North Grafton, Massachusetts, United States of America.
Chan CN; Vaccine & Gene Therapy Institute, Beaverton, Oregon, United States of America.
Bondoc S; Vaccine & Gene Therapy Institute, Beaverton, Oregon, United States of America.
Colarusso A; Department of Biochemistry and Molecular Medicine, University of Montreal, Montreal, Canada.
Starke CE; Vaccine & Gene Therapy Institute, Beaverton, Oregon, United States of America.
Nekorchuk M; Vaccine & Gene Therapy Institute, Beaverton, Oregon, United States of America.
Busman-Sahay K; Vaccine & Gene Therapy Institute, Beaverton, Oregon, United States of America.
Estes JD; Vaccine & Gene Therapy Institute, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Sciences University, Beaverton, Oregon, United States of America.
Martinot AJ; Vaccine & Gene Therapy Institute, Beaverton, Oregon, United States of America.
Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2022 Apr 08; Vol. 18 (4), pp. e1009990. Date of Electronic Publication: 2022 Apr 08 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*
Thrombosis*
Ad26COVS1 ; Animals ; Antibodies, Neutralizing ; COVID-19 Vaccines ; Cricetinae ; Humans ; Inflammation ; Macaca mulatta ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus ; Up-Regulation
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series.
Autorzy:
Pearson JC; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Dionne B; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA.; School of Pharmacy, Northeastern University, Boston, Massachusetts, USA.
Richterman A; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Vidal SJ; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Weiss Z; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Velásquez GE; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Marty FM; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Division of Infectious Diseases, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
Sax PE; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Yawetz S; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Sep 09; Vol. 7 (10), pp. ofaa415. Date of Electronic Publication: 2020 Sep 09 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Targeting cancer stem cells to suppress acquired chemotherapy resistance.
Autorzy:
Vidal SJ; 1] Department of Pathology, Mount Sinai Icahn School of Medicine, New York, NY, USA [2] Columbia University College of Physicians and Surgeons, New York, NY, USA.
Rodriguez-Bravo V; Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Galsky M; Oncology Department, Tisch Cancer Institute, Mount Sinai Icahn School of Medicine, New York, NY, USA.
Cordon-Cardo C; Department of Pathology, Mount Sinai Icahn School of Medicine, New York, NY, USA.
Domingo-Domenech J; Department of Pathology, Mount Sinai Icahn School of Medicine, New York, NY, USA.
Pokaż więcej
Źródło:
Oncogene [Oncogene] 2014 Sep 04; Vol. 33 (36), pp. 4451-63. Date of Electronic Publication: 2013 Oct 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Antineoplastic Agents/*pharmacology
Neoplasms/*therapy
Neoplastic Stem Cells/*drug effects
Animals ; Drug Resistance, Neoplasm ; Humans ; Neoplasms/pathology ; Neoplasms, Experimental ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology ; Tumor Microenvironment/drug effects
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies